Navigation Links
AMT Receives Orphan Drug Designation From the U.S. Food and Drug Administration Duchenne Muscular Dystrophy Gene Therapy
Date:9/24/2010

r meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics (AMT) Holding N.V. only. Undue reliance should not be placed on these statements because, by their nature, they are subject to known and unknown risks and can be affected by factors that are beyond the control of AMT. Actual results could differ materially from current expectations due to a number of factors and uncertainties affecting AMT's business, including, but not limited to, the timely commencement and success of AMT's clinical trials and research endeavors, delays in receiving U.S. Food and Drug Administration or other regulatory approvals (i.e. EMA, Health Canada), market acceptance of AMT's products, effectiveness of AMT's marketing and sales efforts, development of competing therapies and/or technologies, the terms of any future strategic alliances, the need for additional capital, the inability to obtain, or meet, conditions imposed for required governmental and regulatory approvals and consents. AMT expressly disclaims any intent or obligation to update these forward-looking statements except as required by law. For a more detailed description of the risk factors and uncertainties affecting AMT, refer to the prospectus of AMT's initial public offering on June 20, 2007, and AMT's public announcements made from time to time.


'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
2. NephRx Corp. Receives Orphan Drug Designation for NX001 for Prevention of Delayed Kidney Graft Function
3. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
4. NanoSmart™ Pharmaceuticals, Inc. Receives Patent Allowance for Tumor Targeting Platform Technology
5. Renhuang Receives AAA(1) Rating from Chinese Academy of International Trade & Economic Cooperation of Ministry of Commerce
6. Keck Graduate Institute Receives $3.6 Million NIH Grant
7. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
8. IIVS Receives First Mark Twain Ethical Science Award for Successes In Replacing Animals for Chemical and Product Safety Testing
9. Sirnaomics Receives Two SBIR Grants from NIH for Developing siRNA Therapeutics to Treat Glioblastoma and Influenza Infection
10. China Agritech, Inc. Receives $10 Million From Warrant Exercise by The Carlyle Group
11. Chiasma Receives Orphan Drug Designation From the FDA for Octreolin™ for the Oral Treatment of Acromegaly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NY (PRWEB) January 15, 2014 The Microcompetition ... a major disease. One of these latent viruses is the ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... theory, a study found that RA patients have high concentrations ...
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... 15, 2014 AudioNotch is the internet's ... for the treatment of tinnitus. Patients listen to sound ... over a period of weeks to months, their tinnitus volume ... two forms: Notched Music and Notched White Noise. Now, AudioNotch ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... ISELIN, N.J., Oct. 1 SyntheMed, Inc. (OTC,Bulletin ... development,and commercialization of anti-adhesion products and other surgical,implants, ... closing of a,private placement in which it received ... involved the issuance to investors of ten million ...
... Celsis Rapid Detection, a division of,Celsis International plc ... Sullivan,2008 North American Growth Strategy Leadership Award recipient ... and Release of,Pharmaceuticals., "The Celsis Rapid Detection ... pharmaceutical companies to significantly reduce,production cycle times in ...
... SoluLinK, Inc., a leader in,conjugation products and ... of its newest product, the One-Shot ChromaLink ... the components for the rapid,traceable biotinylation of ... sulfo-ChromaLink Biotin linker, a water-soluble, biotin labeling,reagent ...
Cached Biology Technology:SyntheMed Completes $4.0 Million Equity Placement 2Celsis Receives Frost & Sullivan 2008 Best Practices Award 2Celsis Receives Frost & Sullivan 2008 Best Practices Award 3SoluLinK Introduces New One-Shot ChromaLink(TM) Biotin Antibody Labeling Kit with Built-in Biotin Quantification. 2
(Date:4/23/2014)... NY. (Apr. 23 2014) A team ... stem cells (hNSCs) into the brains of nonhuman ... 22 and 24 months found that the hNSCs ... did not cause tumors. , The study will ... Cell Transplantation but is currently freely available ...
(Date:4/23/2014)... who have had a stroke, often suffer motor deficits ... study conducted in Taiwan, that will be published in ... is currently freely available on-line as an unedited early ... one group of stroke victims had their own peripheral ... and a similar group did not, those who received ...
(Date:4/23/2014)... TX (4/23/14) -- Researchers have found evidence of ... factors that increase aggressive behavior in children, especially ... not all children exposed to prenatal smoking will ... will not," said Brian Boutwell, Assistant Professor at ... and senior author on the study. "One ...
Breaking Biology News(10 mins):Study finds long-term survival of human neural stem cells transplanted into primate brain 2Autologous stem cell therapy improves motor function in chronic stroke victims 2Genetics risk, prenatal smoking may predict behavioral problems 2
... skin like a temporary tattoo, can alert marathoners, competitive bikers ... "hit the wall," scientists are reporting. The study, in ACS, ... of the sensor, which also could help soldiers and others ... monitor stamina and fitness. Joseph Wang and colleagues ...
... those painful lip blisters known as cold sores has an internal ... to literally blast its infectious DNA into human cells, scientists are ... the first in a human virus opens the door ... in the Journal of the American Chemical Society . ...
... MINNEAPOLIS/ST. PAUL (July 23, 2013) Mere months after ... the United States swine population, University of Minnesota researchers ... The first-of-its-kind test, which is available now, provides a ... U.S. PEDV strains. Characterized by acute diarrhea ...
Cached Biology News:U of M researchers unveil nation's first porcine virus rapid detection test 2
... The mycobacteria in ... cells to the injection site which enhances ... Freund's Adjuvant is used for the initial ... the subsequent boosts. Antigens (preferably in saline) ...
HiTrap Streptavidin HP, 5 x 1 ml. Category: Chromatography Systems & Accessories, Systems....
...
Request Info...
Biology Products: